First-Trimester Combined Screening

Discover Our Story

Established in 1985, Parvathi Hospital has earned a reputation for providing high-quality, safe, and affordable healthcare.

We offer a comprehensive range of services, from routine checkups to diagnosis and treatment for a full spectrum of women’s and children’s health concerns.Our team of experienced doctors and healthcare professionals are dedicated to providing world-class care.We understand that each patient is unique. We work with you to develop a personalized treatment plan tailored to your specific needs.We continuously update our technology to deliver the latest and most effective treatments. Our passion for patient care has driven us to perform over 30,000 successful deliveries.

Parvathi Hospital is your trusted partner in healthcare, ensuring a healthy and comfortable journey for women and children.

Pregnancy is an exciting time, but it can also come with a mix of emotions and questions. The first trimester combined screening is a prenatal test offered to expecting mothers to assess the baby’s risk for certain chromosomal conditions. At Parvathi Hospital, we understand the importance of informed decision-making during pregnancy. Our team of experts can guide you through the first-trimester combined screening process and answer any questions you may have.

What is First-Trimester Combined Screening?

This screening combines two tests performed in the first trimester of pregnancy:

Blood Test

This test measures the levels of two pregnancy-associated proteins in your blood - pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (free ß-hCG). Abnormal levels of these proteins may indicate an increased risk for chromosomal abnormalities.

Nuchal Translucency Ultrasound

This specialized ultrasound examines the fluid collection at the back of the baby's neck. Increased nuchal translucency thickness can be associated with a higher risk of Down syndrome or other chromosomal conditions.

Who Should Consider First-Trimester Combined Screening?

This screening is typically offered to all pregnant women. However, it may be particularly recommended for women with:

What Does the Screening Tell Me?

The combined screening does not diagnose chromosomal abnormalities. It provides a calculated risk – a percentage chance – of your baby having a condition like Down syndrome or Edwards syndrome.

Important Points to Remember:

A high-risk result does not necessarily mean your baby has a chromosomal abnormality. It indicates a need for further testing, such as chorionic villus sampling (CVS) or amniocentesis.
A low-risk result is reassuring but does not completely eliminate the chance of a chromosomal abnormality.
The decision to undergo first-trimester combined screening is entirely up to you. We encourage you to discuss the pros and cons with your doctor to determine if it's right for you.

Our Doctors

Meet Our Specialist

Dr. Priyadharshika

Obstetrician & Gynaecology

DR. SWATHI APSANI

Gynecology, Laparoscopic Surgeon & Infertility Specialist

Dr. Malleboyina Salomi

Fetel Medicine, Obstetrician & Gynaecology

Dr. Rajani Peethala

Fetel Medicine, Obstetrician & Gynaecology

Dr. Prasanna Gonuguntla

Obstetrics & Gynaecology

FAQ's

01. When is the first-trimester combined screening performed?

The blood test is usually done between 9 and 13 weeks of pregnancy, and the nuchal translucency ultrasound is typically performed between 11 and 13 weeks.

02. What are the limitations of first-trimester combined screening?

This screening cannot diagnose chromosomal abnormalities and may not detect all cases. Additionally, the accuracy of the test can be affected by factors like maternal weight and gestational age.

03. What happens if my screening results are high-risk?

Your doctor will discuss further testing options, such as CVS or amniocentesis, which can provide a definitive diagnosis.

Shopping cart

Let’s Stay In Touch